Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3024% below fair value
$2.89−0.01 (-0.34%)
Close on Nov 18, 2026Market cap $31.39MP/E 18.1Yield –
Nephros gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Nephros's gross profit for the twelve months ending Jun 30, 2026 was $12.70M, up 20.1% year over year. For fiscal 2025 it was $11.63M, up 33.3% from the year before. Over ten years it grew 27.1% a year on average. The highest annual figure on record is $11.63M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.63M | +33.3% |
| FY2024 | Dec 31, 2024 | $8.72M | +3.8% |
| FY2023 | Dec 31, 2023 | $8.41M | +77.7% |
| FY2022 | Dec 31, 2022 | $4.73M | -16.0% |
| FY2021 | Dec 31, 2021 | $5.63M | +14.7% |
| FY2020 | Dec 31, 2020 | $4.91M | -19.2% |
| FY2019 | Dec 31, 2019 | $6.08M | +89.9% |
| FY2018 | Dec 31, 2018 | $3.20M | +39.7% |
| FY2017 | Dec 31, 2017 | $2.29M | +77.1% |
| FY2016 | Dec 31, 2016 | $1.29M | +22.1% |
| FY2015 | Dec 31, 2015 | $1.06M | -11.6% |
| FY2014 | Dec 31, 2014 | $1.20M | +42.4% |
| FY2013 | Dec 31, 2013 | $842.00K | -21.3% |
| FY2012 | Dec 31, 2012 | $1.07M | +23.3% |
| FY2011 | Dec 31, 2011 | $868.00K | -22.6% |
| FY2010 | Dec 31, 2010 | $1.12M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.03M | +44.0% |
| Q1 FY2026 | Mar 31, 2026 | $2.99M | -5.1% |
| Q4 FY2025 | Dec 31, 2025 | $2.76M | +11.6% |
| Q3 FY2025 | Sep 30, 2025 | $2.92M | +35.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.80M | +46.2% |
| Q1 FY2025 | Mar 31, 2025 | $3.15M | +44.2% |
| Q4 FY2024 | Dec 31, 2024 | $2.48M | +22.5% |
| Q3 FY2024 | Sep 30, 2024 | $2.15M | -2.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.91M | -8.0% |
| Q1 FY2024 | Mar 31, 2024 | $2.19M | +3.6% |
| Q4 FY2023 | Dec 31, 2023 | $2.02M | +33.9% |
| Q3 FY2023 | Sep 30, 2023 | $2.19M | +187.9% |
| Q2 FY2023 | Jun 30, 2023 | $2.08M | +49.0% |
| Q1 FY2023 | Mar 31, 2023 | $2.11M | +100.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.51M | +2.6% |
| Q3 FY2022 | Sep 30, 2022 | $762.00K | -44.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.40M | +9.4% |
| Q1 FY2022 | Mar 31, 2022 | $1.05M | -33.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.47M | +13.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.36M | +11.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.28M | +42.5% |
| Q1 FY2021 | Mar 31, 2021 | $1.59M | +6.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.30M | -31.5% |
| Q3 FY2020 | Sep 30, 2020 | $1.23M | -32.7% |
| Q2 FY2020 | Jun 30, 2020 | $895.00K | -34.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.49M | +49.4% |
| Q4 FY2019 | Dec 31, 2019 | $1.90M | +99.2% |
| Q3 FY2019 | Sep 30, 2019 | $1.82M | +91.1% |
| Q2 FY2019 | Jun 30, 2019 | $1.37M | +64.7% |
| Q1 FY2019 | Mar 31, 2019 | $998.00K | +113.7% |
| Q4 FY2018 | Dec 31, 2018 | $954.00K | +21.1% |
| Q3 FY2018 | Sep 30, 2018 | $952.00K | +78.9% |
| Q2 FY2018 | Jun 30, 2018 | $830.00K | +60.5% |
| Q1 FY2018 | Mar 31, 2018 | $467.00K | +2.6% |
| Q4 FY2017 | Dec 31, 2017 | $788.00K | +104.1% |
| Q3 FY2017 | Sep 30, 2017 | $532.00K | +68.4% |
| Q2 FY2017 | Jun 30, 2017 | $517.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $455.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $386.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $316.00K | – |
See a number that looks wrong?